|
Perspectives
Citations 21-30 of 68 total displayed.
|
Past content
(since Apr 1999):
|
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
- Thomas O'Hare, Christopher A. Eide, and Michael W. N. Deininger
Blood 2007; 110: 2242-2249.
[Abstract]
[Full text]
[PDF]
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
- Elise Olsen, Eric Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, Madeleine Duvic, Teresa Estrach, Stanford Lamberg, Gary Wood, Reinhard Dummer, Annamari Ranki, Gunter Burg, Peter Heald, Mark Pittelkow, Maria-Grazia Bernengo, Wolfram Sterry, Liliane Laroche, Franz Trautinger, and Sean Whittaker, for the ISCL/EORTC
Blood 2007; 110: 1713-1722.
[Abstract]
[Full text]
[PDF]
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel
- Ayalew Tefferi, Juergen Thiele, Attilio Orazi, Hans Michael Kvasnicka, Tiziano Barbui, Curtis A. Hanson, Giovanni Barosi, Srdan Verstovsek, Gunnar Birgegard, Ruben Mesa, John T. Reilly, Heinz Gisslinger, Alessandro M. Vannucchi, Francisco Cervantes, Guido Finazzi, Ronald Hoffman, D. Gary Gilliland, Clara D. Bloomfield, and James W. Vardiman
Blood 2007; 110: 1092-1097.
[Abstract]
[Full text]
[PDF]
End points to establish the efficacy of new agents in the treatment of acute leukemia
- Frederick R. Appelbaum, Daniel Rosenblum, Robert J. Arceci, William L. Carroll, Philip P. Breitfeld, Stephen J. Forman, Richard A. Larson, Stephanie J. Lee, Sharon B. Murphy, Susan O'Brien, Jerald Radich, Nancy S. Scher, Franklin O. Smith, Richard M. Stone, and Martin S. Tallman
Blood 2007; 109: 1810-1816.
[Abstract]
[Full text]
[PDF]
Bloodlines: the importance of mentoring for the future of hematology
- Kenneth Kaushansky and Sanford J. Shattil
Blood 2007; 109: 1353-1354.
[Full text]
[PDF]
When is a mouse basophil not a basophil?
- James J. Lee and Michael P. McGarry
Blood 2007; 109: 859-861.
[Abstract]
[Full text]
[PDF]
HBZ, a new important player in the mystery of adult T-cell leukemia
- Jean-Michel Mesnard, Benoît Barbeau, and Christian Devaux
Blood 2006; 108: 3979-3982.
[Abstract]
[Full text]
[PDF]
Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications
- Makio Ogawa, Amanda C. LaRue, and Christopher J. Drake
Blood 2006; 108: 2893-2896.
[Abstract]
[Full text]
[PDF]
Tolerogenic dendritic cells: cytokine modulation comes of age
- Sergio Rutella, Silvio Danese, and Giuseppe Leone
Blood 2006; 108: 1435-1440.
[Abstract]
[Full text]
[PDF]
Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher disease
- Ari Zimran, Deborah Elstein, and Ernest Beutler
Blood 2006; 108: 802-803.
[Full text]
[PDF]
|
|
